Net income decreased 17.1%
Net income changed -17.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -17.1% from the comparable as-filed period.
Revenue changed -12.9% from the comparable as-filed period.
Receivables / revenue changed +1691 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -18.4% from the comparable as-filed period.
Operating cash-flow margin changed -45487 basis points from the comparable as-filed period.
Working capital changed +18.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -211 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed -8317.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.